Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Teichoic acids are essential anionic glycopolymers found within the cell walls of Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae (Brown et al., 2013). They are classified into wall teichoic acids (WTAs), which are covalently linked to peptidoglycan, and lipoteichoic acids (LTAs), which are anchored to the cytoplasmic membrane (Weidenmaier & Peschel, 2008). These molecules are critical for bacterial survival, playing roles in maintaining cell wall integrity, regulating cell division, and facilitating ion homeostasis, particularly for magnesium cations (Swoboda et al., 2010). In the context of human disease, teichoic acids act as potent pro-inflammatory mediators that are recognized by the innate immune system through Toll-like receptor 2 (TLR2), contributing to the pathogenesis of sepsis and inflammation (NIH/PubMed). Because they are unique to bacteria and vital for virulence and adhesion to host tissues, they represent high-value targets for novel antimicrobial therapies and vaccines (Nature Reviews Microbiology). Drugs like daptomycin interact with LTAs to disrupt membrane function, while experimental inhibitors like targocil target the WTA biosynthetic pathway to sensitize resistant strains to conventional antibiotics (PubChem).
Inhibition of teichoic acid biosynthesis (e.g., targeting TarO, TarG, or TarL enzymes), direct binding and sequestration of the polymer to disrupt cell wall assembly, or calcium-dependent interaction with membrane-anchored lipoteichoic acid to induce membrane depolarization.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Teichoic acid (TA) (TA).